Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease
Open accessAbstract
Background: Chronic obstructive pulmonary disease (COPD) (commonly referred to as chronic bronchitis and emphysema) is a chronic lung condition characterised by the inflammation of airways and irreversible destruction of pulmonary tissue leading to progressively worsening dyspnoea. It is a leading international cause of disability and death in adults. Evidence suggests that there is an increased prevalence of anxiety disorders in people with COPD. The severity of anxiety has been shown to correlate with the severity of COPD, however anxiety can occur with all stages of COPD severity. Coexisting anxiety and COPD contribute to poor health outcomes in terms of exercise tolerance, quality of life and COPD exacerbations. The evidence for treatment of anxiety disorders in this population is limited, with a paucity of evidence to support the efficacy of medication-only treatments. It is therefore important to evaluate psychological therapies for the alleviation of these symptoms in people with COPD. Objectives: To assess the effects of psychological therapies for the treatment of anxiety disorders in people with chronic obstructive pulmonary disease. Search methods: We searched the specialised registers of two Cochrane Review Groups: Cochrane Common Mental Disorders (CCMD) and Cochrane Airways (CAG) (to 14 August 2015). The specialised registers include reports of relevant randomised controlled trials from The Cochrane Library, MEDLINE, Embase, and PsycINFO. We carried out complementary searches on PsycINFO and CENTRAL to ensure no studies had been missed. We applied no date or language restrictions. Selection criteria: We considered all randomised controlled trials (RCTs), cluster-randomised trials and cross-over trials of psychological therapies for people (aged over 40 years) with COPD and coexisting anxiety disorders (as confirmed by recognised diagnostic criteria or a validated measurement scale), where this was compared with either no intervention or education only. We included studies in which the psychological therapy was delivered in combination with another intervention (co-intervention) only if there was a comparison group that received the co-intervention alone. Data collection and analysis: Two review authors independently screened citations to identify studies for inclusion and extracted data into a pilot-tested standardised template. We resolved any conflicts that arose through discussion. We contacted authors of included studies to obtain missing or raw data. We performed meta-analyses using the fixed-effect model and, if we found substantial heterogeneity, we reanalysed the data using the random-effects model. Main results: We identified three prospective RCTs for inclusion in this review (319 participants available to assess the primary outcome of anxiety). The studies included people from the outpatient setting, with the majority of participants being male. All three studies assessed psychological therapy (cognitive behavioural therapy) plus co-intervention versus co-intervention alone. We assessed the quality of evidence contributing to all outcomes as low due to small sample sizes and substantial heterogeneity in the analyses. Two of the three studies had prespecified protocols available for comparison between prespecified methodology and outcomes reported within the final publications. We observed some evidence of improvement in anxiety over 3 to 12 months, as measured by the Beck Anxiety Inventory (range from 0 to 63 points), with psychological therapies performing better than the co-intervention comparator arm (mean difference (MD) -4.41 points, 95% confidence interval (CI) -8.28 to -0.53; P = 0.03). There was however, substantial heterogeneity between the studies (I2 = 62%), which limited the ability to draw reliable conclusions. No adverse events were reported. Authors' conclusions: We found only low-quality evidence for the efficacy of psychological therapies among people with COPD with anxiety. Based on the small number of included studies identified and the low quality of the evidence, it is difficult to draw any meaningful and reliable conclusions. No adverse events or harms of psychotherapy intervention were reported. A limitation of this review is that all three included studies recruited participants with both anxiety and depression, not just anxiety, which may confound the results. We downgraded the quality of evidence in the 'Summary of findings' table primarily due to the small sample size of included trials. Larger RCTs evaluating psychological interventions with a minimum 12-month follow-up period are needed to assess long-term efficacy. © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
11 of 82 cited sources checked · 7 supported · 1 flagged · accuracy not yet measured
- Premisecitation
There is an increased prevalence of anxiety disorders in people with COPD.
“Evidence suggests that there is an increased prevalence of anxiety disorders in people with COPD (Maurer 2008).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Maurer 2008 source
- Findingown data
The mean quality of life - emotional composite in the intervention groups was 0.30 standard deviations lower (1.03 lower to 0.44 higher).
“The mean quality of life -emotional composite in the intervention groups was 0.30 standard deviations lower (1.03 lower to 0.44 higher)”
Quote in the paperNot a substantial claim - Findingown data
The mean exercise capacity in the intervention groups was 2.78 lower (58.49 lower to 52.94 higher).
“The mean exercise capacity in the intervention groups was 2.78 lower (58.49lower to 52.94 higher)”
Quote in the paperNot a substantial claim - Findingown data
For quality of life - physical composite, the short-term follow-up SMD was -0.22 (95% CI -0.45 to 0.01; P = 0.06).
“short-term (0 to 3 months; SMD -0.22, 95% CI -0.45 to 0.01; P = 0.06)”
Quote in the paperNot a substantial claim - Findingown data
Beneficial findings were observed in favour of the psychological therapy group for anxiety (p = 0.03).
“Beneficial findings were observed in favour of the psychological therapy group (p= 0.03)”
Quote in the paperSubstantial claim
- Findingown data
For quality of life - emotional composite, the short-term follow-up SMD was 0.05 (95% CI -0.18 to 0.28).
“short-term (0 to 3 months; (SMD 0.05, 95% CI -0.18 to 0.28)”
Quote in the paperNot a substantial claim - Findingnone given
The mean anxiety in the control groups was 15.51.
“The mean anxiety in the control groups was 15.51”
Quote in the paperNot a substantial claim - Findingown data
The mean quality of life - physical composite in the control groups was 45.08.
“The mean quality of life -physical composite in the control groups was 45.08”
Quote in the paperNot a substantial claim - Findingnone given
No studies reported on adverse events.
“No studies reported on adverse events”
Quote in the paperNot a substantial claim - Findingown data
The mean quality of life - physical composite in the intervention groups was 0.40 standard deviations lower (0.88 lower to 0.08 higher).
“The mean quality of life -physical composite in the intervention groups was 0.40 standard deviations lower (0.88 lower to 0.08 higher)”
Quote in the paperNot a substantial claim - Findingown data
The mean anxiety in the intervention groups was 4.41 lower (8.28 to 0.53 lower).
“The mean anxiety in the intervention groups was 4.41 lower (8.28 to 0.53 lower)”
Quote in the paperSubstantial claim - Findingown data
For quality of life - emotional composite, the long-term follow-up SMD was -0.09 (95% CI -0.32 to 0.14).
“long-term follow-up (6 to 12 months; (SMD -0.09, 95% CI -0.32 to 0.14)”
Quote in the paperNot a substantial claim - Findingown data
The exercise capacity analysis included 268 participants from 2 studies.
“268 (2 studies)”
Quote in the paperNot a substantial claim - Findingcitation
Levels of anxiety were half that of the control population by final follow-up in Gillis 1995.
“with levels of anxiety half that of the control population by final follow-up (Gillis 1995)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gillis 1995 source
- Findingown data
The anxiety analysis included 319 participants from 3 studies.
“319 (3 studies)”
Quote in the paperSubstantial claim - Findingown data
No evidence of any effect was observed for SGRQ and the emotional composite of SF36 (SMD -0.30, 95% CI -1.03 to 0.44; participants = 289; studies = 2; I2 = 82%).
“No evidence of any effect was observed for SGRQ and the emotional composite of SF36 (SMD -0.30, 95% CI -1.03 to 0.44; participants = 289; studies = 2; I 2 = 82%); Analysis 1.2).”
Quote in the paperNot a substantial claim - Findingcitation
In the Kunik 2008 study, only one of the eight CRQ categories produced results in favour of the CBT group for general health (end of treatment eight-week score: intervention mean 34.14 + 28.53, control mean 37.76 + 27.74; P = 0.05).
“Alongside SF36, CRQ was also reported in the Kunik 2008 study with only one of the eight categories producing results in favour of the CBT group for general health (end of treatment eight-week score: intervention arm mean 34.14 + 28.53 and control arm mean 37.76 + 27.74; P = 0.05).”
Quote in the paperNot a substantial claim - Findingown data
The review included three studies (five full-text articles) in the final qualitative and quantitative analyses.
“From these, we included three studies (five full-text articles) in the final qualitative and quantitative analyses.”
Quote in the paperSubstantial claim - Findingown data
Imprecision was identified particularly when examining exercise capacity, with wide confidence intervals around the treatment effect.
“Imprecision was identified particularly when examining exercise capacity with the presence of wide confidence intervals around the treatment effect.”
Quote in the paperSubstantial claim - Findingown data
Compared with control, there was no significant difference in the number of steps taken as measured by the Six Minute Walking Distance when engaged in psychological therapies (MD -2.78, 95% CI -58.49 to 52.94; participants = 268; studies = 2; I2 = 80%).
“Compared with the control, there was no significant difference in the number of steps taken as measured by the Six Minute Walking Distance (6MWD) when engaged in psychological therapies: (MD -2.78, 95% CI -58.49 to 52.94, participants = 268; studies = 2; I 2 = 80%; Analysis 1.3).”
Quote in the paperNot a substantial claim - Findingnone given
No adverse events were reported for any of the included studies.
“No adverse events were reported for any of the included studies.”
Quote in the paperNot a substantial claim - Findingown data
No evidence of an effect was noted for exercise capacity or quality of life, even after subgroup analyses.
“We did not note any evidence of an effect for exercise capacity (Analysis 2.2) or quality of life (Analysis 2.3, Analysis 2.4), even a er sub group analyses.”
Quote in the paperSubstantial claim - Findingnone given
All three included studies recruited people with diagnosed COPD and anxiety using a validated tool.
“All three studies recruited people with diagnosed COPD and anxiety using a validated tool.”
Quote in the paperNot a substantial claim - Findingown data
None of the three included studies included adverse events or objective markers of lung disease, such as FEV1, as an outcome.
“From the prespecified outcomes identified as being important for this review, none of the three included studies included as an outcome either adverse events or objective markers of lung disease, such as FEV1.”
Quote in the paperSubstantial claim - Findingown data
Three studies including 319 participants contributed data to the comparison of psychological therapies and co-intervention versus co-intervention alone.
“Three studies including 319 participants contributed data to this comparison.”
Quote in the paperSubstantial claim - Findingown data
In both anxiety and quality-of-life outcomes, results became better (favoured intervention more) with longer follow-up compared to immediately post treatment.
“In both anxiety and quality-oflife outcomes, results became better (favoured intervention more) with longer follow-up compared to immediately post treatment.”
Quote in the paperNot a substantial claim - Findingown data
Two studies with 289 participants reported quality of life through three different tools: SGRQ, SF36 and CRQ.
“Two studies with 289 participants reported quality of life through use of three different tools, being SGRQ, SF36 and CRQ.”
Quote in the paperNot a substantial claim - Findingown data
No included studies reported on FEV1.
“No studies reported on FEV1.”
Quote in the paperNot a substantial claim - Findingnone given
Exercise capacity in the psychotherapy group of the de Godoy 2003 study improved almost twice as much from baseline as the control population (P = 0.11).
“Exercise capacity in the psychotherapy group of the de Godoy 2003 study improved almost twice as much from baseline as the control population (P = 0.11).”
Quote in the paperNot a substantial claim - Findingown data
Psychological therapies were observed to be more effective for the treatment of anxiety compared with co-interventions or usual care (MD -4.41, 95% CI -8.28 to -0.53; participants = 319; I2 = 62%; P = 0.03).
“Psychological therapies were observed to be more effective for the treatment of anxiety compared with co-interventions or usual care (mean difference (MD) -4.41, 95% confidence interval (CI) -8.28 to -0.53; participants = 319; I 2 = 62%; P = 0.03; Analysis 1.1; Figure 4).”
Quote in the paperSubstantial claim - Findingown data
Length of stay and readmission rate were not effectively evaluated in any of the three included studies.
“Length of stay and readmission rate was also not effectively evaluated in any of the three studies.”
Quote in the paperNot a substantial claim - Findingown data
Psychological interventions were observed to be more effective than control for the combination of SGRQ and the physical composite of SF36 (SMD -0.40, 95% CI -0.88 to -0.08; participants = 289; studies = 2; I2 = 61%; P = 0.10).
“Psychological interventions were observed to be more effective compared to the control population for the combination of SGRQ and the physical composite of SF36 (standardised mean difference (SMD) -0.40, 95% CI -0.88 to -0.08; participants = 289; studies = 2; I 2 = 61%; P = 0.10).”
Quote in the paperSubstantial claim - Findingown data
Psychological therapies compared with co-intervention do not significantly improve quality of life physical composite in people with COPD (SMD -0.40, 95% CI -0.88 to 0.08, P = 0.1).
“Subtotal *** 143 146 100% -0.4[-0.88,0.08]Heterogeneity: Tau =0.08; Chi =2.56, df=1(P=0.11);I =60.97%Test for overall effect: Z=1.63(P=0.1)”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
Psychological therapies compared with co-intervention reduce anxiety in people with COPD (mean difference -4.41, 95% CI -8.28 to -0.53, P = 0.03).
“Total *** 157 162 100% -4.41[-8.28,-0.53]Heterogeneity: Tau =7.21; Chi =5.2, df=2(P=0.07);I =61.51%Test for overall effect: Z=2.23(P=0.03)”
Quote in the paperSubstantial claim0 of 3 sources checked - Findingown data
In the short term (0 to 3 months), psychological therapies compared with co-intervention do not significantly improve six minute walking distance in people with COPD (MD 29.35, 95% CI -30.13 to 88.82, P = 0.33).
“Subtotal *** 132 136 100% 29.35[-30.13,88.82]Heterogeneity: Tau =0; Chi =0.2, df=1(P=0.65);I =0% Test for overall effect: Z=0.97(P=0.33)”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingown data
In the long term (6 to 12 months), psychological therapies compared with co-intervention do not significantly reduce anxiety in people with COPD (MD -4.30, 95% CI -10.57 to 1.97, P = 0.18).
“Subtotal *** 143 146 100% -4.3[-10.57,1.97]Heterogeneity: Tau =16.37;Chi =4.92, df=1(P=0.03);I =79.66%Test for overall effect: Z=1.34(P=0.18)”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
In the long term (6 to 12 months), psychological therapies compared with co-intervention do not significantly improve six minute walking distance in people with COPD (MD -30.08, 95% CI -170.92 to 110.77, P = 0.68).
“Subtotal *** 132 136 100% -30.08[-170.92,110.77]Heterogeneity: Tau =8340.78;Chi =5.01, df=1(P=0.03);I =80.04%Test for overall effect: Z=0.42(P=0.68)”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingown data
In the short term (0 to 3 months), psychological therapies compared with co-intervention reduce anxiety in people with COPD (MD -3.86, 95% CI -6.63 to -1.10, P = 0.01).
“Subtotal *** 157 162 100% -3.86[-6.63,-1.1]Heterogeneity: Tau =1.16; Chi =2.47, df=2(P=0.29);I =19.09%Test for overall effect: Z=2.74(P=0.01)”
Quote in the paperSubstantial claim0 of 3 sources checked - Findingown data
In the short term (0 to 3 months), psychological therapies compared with co-intervention do not significantly improve quality of life emotional composite in people with COPD (SMD -0.17, 95% CI -0.93 to 0.60, P = 0.67).
“Subtotal *** 143 146 100% -0.17[-0.93,0.6]Heterogeneity: Tau =0.26; Chi =6.25, df=1(P=0.01);I =84% Test for overall effect: Z=0.42(P=0.67)”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingreasoning
All three included studies reported issues with either prespecified sample sizes not being met or a small sample limiting the ability to draw reliable conclusions.
“In particular, all three studies reported issues with either prespecified sample sizes not being met ( Kunik 2008;Hynninen 2010) or a small sample limiting the ability to draw reliable conclusions from the results (de Godoy 2003, in which there was no mention of sample size calculations).”
Quote in the paperNot a substantial claim - Findingown data
Psychological therapies compared with co-intervention do not significantly improve quality of life emotional composite in people with COPD (SMD -0.30, 95% CI -1.03 to 0.44, P = 0.43).
“Subtotal *** 143 146 100% -0.3[-1.03,0.44]Heterogeneity: Tau =0.24; Chi =5.68, df=1(P=0.02);I =82.39%Test for overall effect: Z=0.79(P=0.43)”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
In the short term (0 to 3 months), psychological therapies compared with co-intervention do not significantly improve quality of life physical composite in people with COPD (SMD -0.30, 95% CI -0.73 to 0.13, P = 0.17).
“Subtotal *** 143 146 100% -0.3[-0.73,0.13]Heterogeneity: Tau =0.06; Chi =2.14, df=1(P=0.14);I =53.22%Test for overall effect: Z=1.37(P=0.17)”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
Psychological therapies compared with co-intervention do not significantly improve six minute walking distance in people with COPD (MD -2.78, 95% CI -58.49 to 52.94, P = 0.92).
“Total *** 132 136 100% -2.78[-58.49,52.94]Heterogeneity: Tau =0; Chi =5.01, df=1(P=0.03);I =80.04%Test for overall effect: Z=0.1(P=0.92)”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingown data
In a meta-analysis of 3 studies with 319 participants, psychological therapies compared with co-intervention reduced anxiety, with a mean difference of -4.41 (95% CI -8.28 to -0.53).
“1 Anxiety 3 319 Mean Difference (IV, Random, 95% CI) -4.41 [-8.28, -0.53]”
Quote in the paperSubstantial claim - Study design and conductown data
The quality of evidence for the exercise capacity outcome was low.
“⊕⊕⊝⊝ low 1,4”
Quote in the paperNot a substantial claim - Study design and conductown data
The quality of evidence for the anxiety outcome was low.
“⊕⊕⊝⊝ low 1,2”
Quote in the paperSubstantial claim - Interpretationown data
Sub-group analyses for quality of life - emotional composite resulted in better treatment outcomes long-term.
“Sub-group analyses separating short-term (0 to 3 months; (SMD 0.05, 95% CI -0.18 to 0.28) and long-term follow-up (6 to 12 months; (SMD -0.09, 95% CI -0.32 to 0.14) resulted in better treatment outcomes long-term.”
Quote in the paperNot a substantial claim - Study design and conductown data
The quality of evidence for the quality of life - emotional composite outcome was low.
“⊕⊕⊝⊝ low 1,3”
Quote in the paperNot a substantial claim - Interpretationown data
Sub-group analyses for quality of life - physical composite resulted in better treatment outcomes long-term.
“Sub-group analyses separating short-term (0 to 3 months; SMD -0.22, 95% CI -0.45 to 0.01; P = 0.06) and long-term follow-up (6 to 12 months; SMD -0.30, 95% CI -0.53 to -0.06; P = 0.01) resulted in better treatment outcomes long-term.”
Quote in the paperSubstantial claim - Study design and conductown data
The quality of evidence for the quality of life - physical composite outcome was low.
“⊕⊕⊝⊝ low 1,3”
Quote in the paperNot a substantial claim - Premisecitation
Co-morbid anxiety in an elderly population with COPD is a significant predictor of the frequency of hospital admissions.
“Co-morbid anxiety in an elderly population with COPD has been suggested as a significant predictor of the frequency of hospital admissions (Yohannes 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Yohannes 2000 source
- Premisecitation
The association between anxiety/panic and dyspnoea/COPD had been explained by various psychological theories.
“Furthermore the association between anxiety/panic and dyspnoea/COPD had been explained by various psychological theories (Clark 1986;Livermore 2010b).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Clark 1986 source
- cites Livermore 2010b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The results of a Cochrane Review evaluating the effects of pharmacological interventions for anxiety in people with COPD are inconclusive.
“The results of a Cochrane Review evaluating the effects of pharmacological interventions for anxiety in people with COPD are inconclusive (Usmani 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Usmani 2011 source
- Premisecitation
The impact of anxiety on outcomes in COPD was shown after adjusting for other potential confounders such as general health status, other medical conditions and COPD severity.
“Importantly, the impact of anxiety on these outcomes was shown a er adjusting for other potential confounders such as general health status, other medical conditions and COPD severity (Brenes 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brenes 2003 source
- Premisecitation
Evidence that pharmacological therapies provide statistically or clinically significant benefits for anxiety in people with COPD is limited.
“Evidence that pharmacological therapies (anti-anxiety or antidepressant medications, or both) provide statistically or clinically significant benefits for this group of patients is limited (Usmani 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Usmani 2011 source
- Premisecitation
People with anxiety and panic disorders interpret threats as more dangerous due to a higher awareness of cues such as dyspnoea and tachycardia.
“As such, people with anxiety and panic disorders interpret threats as more dangerous due to a higher awareness of cues such as dyspnoea and tachycardia (Mikkelsen 2004).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mikkelsen 2004 source
- Premisecitation
Therapies targeting the reduction of psychological stressors should be expected to improve quality of life.
“As a result, therapies targeting the reduction of psychological stressors should be expected to improve quality of life (Ries 1995;Rose 2002;Baraniak 2011).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Anxiety and depression are more strongly related to functional status than the severity of COPD.
“Kim 2000 reported that anxiety and depression were more strongly related to functional status than the severity of COPD.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kim 2000 source
- Premisecitation
Underlying psychological distress can contribute to an increased risk of symptom exacerbations, particularly those treated in the person's own environment.
“Alternatively, underlying psychological distress can contribute to an increased risk of symptom exacerbations, particularly those treated in the person's own environment (Laurin 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Laurin 2011 source
- Interpretationown data
It is difficult to determine the presence of publication bias and systematic underestimation or overestimation of the underlying beneficial or harmful effect due to inclusion of only three studies.
“It is difficult to determine the presence of publication bias and systematic underestimation or overestimation of the underlying beneficial or harmful effect due to inclusion of only three studies.”
Quote in the paperSubstantial claim - Interpretationown data
Subgroup analyses for duration of follow-up for both anxiety and quality of life indicate the potential for greater benefits in favour of the psychological intervention given more time.
“Of note however, sub-group analyses for duration of follow-up for both anxiety and quality of life indicate the potential for greater benefits in favour of the psychological intervention given more time (in the presence of wider confidence intervals due to small number of relevant studies).”
Quote in the paperNot a substantial claim - Interpretationown data
Based on the small number of included studies (only three), it is difficult to draw any meaningful and reliable conclusions.
“Based on the small number of included studies within this review (only three), it is difficult to draw any meaningful and reliable conclusions.”
- Also stated in: § A U T H O R S ' C O N C L U S I O N S Implications for practice · plain
“Based on the small number of included studies identified for inclusion within this review (only three), it is difficult to draw any meaningful and reliable conclusions.”
Quote in the paperSubstantial claim - Also stated in: § A U T H O R S ' C O N C L U S I O N S Implications for practice · plain
- Study design and conductown data
Only one included study (Kunik 2008) adequately reported the method of sequence generation, using a computer program with blocks.
“Only one study adequately reported on method of sequence generation (Kunik 2008) using a computer program with blocks to provide appropriately equal numbers per class of COPD.”
Quote in the paperNot a substantial claim - Interpretationreasoning
A limitation of the review is that all three included studies recruited participants with both anxiety and depression, not just anxiety, which may confound the results.
“A limitation of this review is that all three included studies recruited participants with both anxiety and depression, not just anxiety, which may confound the results, as presence of co-morbid depression may have over estimated or under estimated the effect of intervention in different participants”
Quote in the paperSubstantial claim - Interpretationreasoning
Psychological interventions may take longer to work than during the treatment phase alone.
“This suggests that psychological interventions may take longer to work than during the treatment phase alone.”
Quote in the paperSubstantial claim - Interpretationreasoning
There is insufficient information to draw reliable conclusions about whether psychological therapies are beneficial for people with COPD with anxiety.
“As such there is insufficient information to draw reliable conclusions about whether psychological therapies are beneficial for people with COPD with anxiety (see Summary of findings for the main comparison).”
Quote in the paperSubstantial claim - Interpretationreasoning
The quality of the 6MWD outcome was downgraded due to imprecision.
“As such the quality of the 6MWD outcome was downgraded due to imprecision.”
Quote in the paperSubstantial claim - Interpretationreasoning
Considering the small number of included studies and limited reporting for each outcome, the overall completeness and applicability of evidence is poor.
“Considering the small number of included studies and limited reporting for each of the outcomes, the overall completeness and applicability of evidence is poor.”
Quote in the paperSubstantial claim - Interpretationreasoning
Due to the small number of included studies and broad classification of psychological therapies, the review likely contains indirectness through varying interventions, comparators, populations, outcomes and reporting tools.
“Due to the small number of included studies and broad classification of psychological therapies, it is likely that this review contains indirectness through varying interventions, comparators, populations and even outcomes and the use of different reporting tools.”
Quote in the paperSubstantial claim - Interpretationreasoning
Because the three included studies were from three different countries and different healthcare settings, it is difficult to determine the extent to which the results can be generalised.
“As the three studies identified for inclusion within the review were from three different countries and different healthcare settings, it is difficult to determine the extent to which the results can be generalised.”
Quote in the paperSubstantial claim - Study design and conductown data
In Hynninen 2010, blinding of participants and personnel was at high risk of performance bias because neither participants nor therapists were blinded.
“Blinding of participants and personnel (performance bias) All outcomes High risk Neither participants nor therapists were blinded to the intervention”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hynninen 2010 source
- Study design and conductown data
In Hynninen 2010, selective reporting was at low risk of reporting bias because a prespecified protocol was available and no selective reporting was identified.
“Selective reporting (reporting bias) Low risk Prespecified protocol available and no selective reporting identified”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hynninen 2010 source
- Study design and conductown data
In Hynninen 2010, incomplete outcome data was at low risk of attrition bias because reasons for attrition were reported and intention-to-treat analysis was used.
“Incomplete outcome data (attrition bias) All outcomes Low risk Reasons for attrition reported in participant flow chart.Missing outcome data at one measurement point did not preclude analysis as mixed models with random effect was used for analysis; Intention-to-treat analysis occurred”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hynninen 2010 source
- Classified as probably not a substantial claim. 57
- May combine two claims. 45
- The quote only partly states this claim. 3
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnother systematic review and meta-analysis of complex interventions for depression and anxiety in COPD identified 28 studies for inclusion.
“Another systematic review and metaanalysis of complex interventions for depression and anxiety in COPD identified 28 studies for inclusion (Coventry 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Coventry 2013 source
The paper is a systematic review and meta-analysis of complex interventions for depression and anxiety in COPD, but its Characteristics of Populations section says 32 studies met the inclusion criteria, not 28. The Abstract reports that 29 trials were included in the meta-analysis. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrevalence rates for anxiety disorders in people with COPD are 28%-36%.
“Studies have suggested prevalence rates for anxiety disorders of 28%-36% in people with COPD (Di Marco 2006;Yohannnes 2006).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites Di Marco 2006 source
- cites Yohannnes 2006
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe severity of anxiety correlates with the severity of COPD and the presence of lower PaO.
“Moreover, the severity of anxiety has been shown to correlate with the severity of COPD and the presence of lower PaO (partial pressure of oxygen in the blood, an indicator of severity of COPD) (Elassal 2014).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Elassal 2014 source
May combine two claims.
PremisecitationCOPD is associated with a higher risk of anxiety, and co-morbid COPD and anxiety is related to poor health outcomes in terms of exercise tolerance, quality of life, COPD exacerbations, inappropriate use of medications and persistence of smoking as a coping strategy for anxiety management.
“COPD is associated with a higher risk of anxiety, and co morbid COPD and anxiety is related to poor health outcomes in terms of exercise tolerance, quality of life, COPD exacerbations (Eisner 2010), inappropriate use of medications and persistence of smoking as a coping strategy for anxiety management (Royal College of Physcians).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Eisner 2010 source
- cites Royal College of Physcians
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBy compromising health status, mood disorders lead to increased risk of hospitalisation and re-hospitalisation and hence also increase direct and indirect costs to the health system.
“By compromising health status, mood disorders lead to increased risk of hospitalisation and re-hospitalisation (Gudmundsson 2005) and hence also increase direct and indirect costs to the health system.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Gudmundsson 2005 source
The Abstract and Discussion report an increased risk of rehospitalisation among COPD patients with anxiety and low health status. They do not establish that mood disorders cause poor health status or increased hospitalisation generally; the Discussion explicitly reports no association between depression and readmission. The cost statement follows the citation as the citing authors’ inference, rather than a finding attributed to this source. (LLM, conf=0.89)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationCo-morbid depression is a strong predictor of anxiety, which confounds anxiety symptoms making treatment more difficult.
“Indeed, co-morbid depression is known to be a strong predictor of anxiety (DiNicola 2013), which confounds anxiety symptoms making treatment more difficult (Atlantis 2013).”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationAmong people with COPD, anxiety is related to poorer health outcomes including worse submaximal exercise performance, greater risk of self-reported functional limitations and a higher longitudinal risk of COPD exacerbations.
“A recent study has shown that among people with COPD, anxiety is related to poorer health outcomes including worse submaximal exercise performance, greater risk of self-reported functional limitations and a higher longitudinal risk of COPD exacerbations (Eisner 2010).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Eisner 2010 source
Classified as probably not a substantial claim.
Study design and conductcitationWe used the Chi2 and I2 statistics to quantify inconsistency across studies in combination with visual inspection of the data.
“We used the Chi 2 (Deeks 2011) and I 2 statistics (Higgins 2003) to quantify inconsistency across studies in combination with visual inspection of the data for differences between studies (e.g.types of interventions, participants etc.).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites Deeks 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites Higgins 2003 source
May combine two claims.
PremisecitationIn Coventry 2013, subgroup analyses identified small but non-significant effects on self-reported anxiety symptoms post-treatment for cognitive and behavioural interventions (SMD -0.17; 95% CI -0.35 to 0.01; 7 studies) and relaxation (SMD -0.18; 95% CI -0.67 to 0.30; 3 studies), but no evidence of any effect for self-management education (SMD -0.00; 95% CI -0.17 to 0.16; 5 studies).
“Subgroup analyses identified small but non-significant effects on self-reported anxiety symptoms post-treatment for cognitive and behavioural interventions (SMD -0.17; 95% CI -0.35 to 0.01; 7 studies) and relaxation (SMD -0.18; 95% CI -0.67 to 0.30; 3 studies), but observed no evidence of any effect for selfmanagement education (SMD -0.00; 95% CI -0.17 to 0.16; 5 studies).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Coventry 2013 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationCoventry 2013 observed an improvement with the intervention for multi-component exercise training, though the sample included substantial heterogeneity (SMD -0.47; 95% CI -0.66 to -0.28; P = 0.002; 14 studies; I2 = 63.3%).
“This review observed an improvement with the intervention for multi-component exercise training, though the sample included substantial heterogeneity (SMD -0.47; 95% CI -0.66 to -0.28; P = 0.002; 14 studies; I 2 = 63.3%;Coventry 2013).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites Coventry 2013 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
The quote only partly states this claim.
Findingown dataFor quality of life - physical composite, the long-term follow-up SMD was -0.30 (95% CI -0.53 to -0.06; P = 0.01).
“long-term follow-up (6 to 12 months; SMD -0.30, 95% CI -0.53 to -0.06; P = 0.01)”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Findingown dataThe quality of life - physical composite analysis included 289 participants from 2 studies.
“289 (2 studies)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThe mean quality of life - emotional composite in the control groups was 52.3.
“The mean quality of life -emotional composite in the control groups was 52. 3”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe mean exercise capacity in the control groups was 839.
“The mean exercise capacity in the control groups was 839”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationThe Kunik 2008 study examined 6MWD at 8 weeks (post-intervention) and again at 12 months' follow-up with a difference in favour of the control arm at 12 months (P = 0.05).
“The Kunik 2008 study which examined 6MWD at 8 weeks (post-intervention) and again at 12 months' follow-up with a difference in favour of the control arm at 12 months (P = 0.05).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kunik 2008 source
May combine two claims.
FindingcitationAuthors reported that group means at beginning of the follow-up period were not equal (P < 0.01), contributing to the spurious finding.
“However, authors reported that group means at beginning of the follow-up period were not equal (P < 0.01), contributing to the spurious finding.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Findingown dataThe quality of life - emotional composite analysis included 289 participants from 2 studies.
“289 (2 studies)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataTwo studies reported on quality of life, with one study (Kunik 2008) reporting both SF36 and CRQ.
“Two studies reported on quality of life with one study (Kunik 2008) reporting both SF36 and CRQ.”
- Also stated in: § Quality of life -emotional composite SGRQ and SF36 Follow-up: 6-12 months · plain
“Two studies reported on quality of life with one study (Kunik 2008) reporting both SF36 and CRQ.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kunik 2008 source
- Also stated in: § Quality of life -emotional composite SGRQ and SF36 Follow-up: 6-12 months · plain
May combine two claims.
Findingown dataOnly one study (Kunik 2008) reported dyspnoea via CRQ, with an improvement in the CBT group over control at eight-week end-of-treatment follow-up (intervention mean 3.36 + 1.64; control mean 3.51 + 1.59; P = 0.02).
“Only one study (Kunik 2008) reported dyspnoea via CRQ, with an improvement in the CBT group over that of control at eight-week end-of-treatment follow-up (intervention group mean 3.36 + 1.64; control group mean 3.51 + 1.59; P = 0.02).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSubstantial heterogeneity was identified in all meta-analyses across studies, suggesting the possibility of true differences in the underlying treatment effect.
“Substantial heterogeneity was identified in all meta-analyses across studies, suggesting the possibility of these being true differences in the underlying treatment effect.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere was substantial heterogeneity (I2 = 62%) in the anxiety meta-analysis, which limits the reliability of the findings.
“However, there was substantial heterogeneity (I 2 = 62%), which limits the reliability of the findings.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataEach included study reported difficulties with sample size, with two unable to meet target recruitment and the third not reporting a prespecified sample size calculation.
“Each study reported difficulties with sample size, two being unable to meet the target recruitment number (Kunik 2008;Hynninen 2010) and the third (de Godoy 2003) not reporting a prespecified sample size calculation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataSample sizes ranged from n = 30 in de Godoy 2003, n = 51 in Hynninen 2010, and n = 238 in Kunik 2008.
“Samples sizes ranged from n = 30 in de Godoy 2003, n = 51 in Hynninen 2010 and the largest being n = 238 in Kunik 2008.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenThe majority of participants in this review were men.
“Also important to note is that the majority of the participants of this review were men.”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationNo studies provided data specifically on length of stay or hospital readmission rates; the Kunik 2008 study indirectly examined this and found no differences between groups in the ratio of pre-treatment to post-treatment outpatient visits, hospital admissions, mental health visits and emergency visits per month per participant.
“No studies provided data specifically on length of stay or hospital readmission rates.However the Kunik 2008 study did indirectly examine this by tracking the number of treatment visits pre and post study.No differences were observed for the ratio of pre treatment to post treatment between groups for outpatient visits, hospital admissions, mental health visits and emergency visits per month, per”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataSeven studies were awaiting classification and two were ongoing at the time of review completion.
“Seven studies are awaiting classification and two were ongoing at the time of review completion (Figure 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor anxiety, short-term (0 to 3 month follow-up) benefits favoured the intervention arm (MD -3.86; 95% CI -6.63 to -1.10; P = 0.006; I2 = 19%), while these findings were not maintained long-term (6 to 12 months; MD -4.30; 95% CI -10.57 to 1.97; P = 0.18; I2 = 80%).
“In the case of anxiety, short-term (0 to 3 month follow-up) benefits were seen in favour of the intervention arm with a MD of -3.86; 95% CI of -6.63 to -1.10 and P = 0.006 (I 2 = 19%), whilst these findings were not maintained long-term (6 to 12 months; MD -4.30 with 95% CI of -10.57 to 1.97 and P = 0.18; I 2 = 80%; Analysis 2.1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe quality of evidence in this review overall was low, with two of the three studies having prespecified protocols available for comparison to methods and outcomes reported in the final publications.
“The quality of evidence in this review overall was low, with two of the three studies having prespecified protocols available for comparison to methods, and outcomes reported on within the final publications.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataThirteen potentially eligible studies (15 full-text articles) were excluded from the review.
“We excluded 13 of the potentially eligible studies (15 full-text articles) from the review due to no diagnosis of anxiety at baseline”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingnone givenAll three included studies measured anxiety using the Beck Anxiety Inventory (BAI).
“All three studies measured anxiety using the Beck Anxiety Inventory (BAI).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenAll three included studies were single-centre, parallel RCTs from Brazil, Norway and the USA.
“All three studies were single-centre, parallel RCTs coming from Brazil (de Godoy 2003), Norway (Hynninen 2010) and the USA (Kunik 2008).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataIn the Kunik 2008 study, of 256 eligible participants, 238 were randomised but only 181 attended their first session, a 24% attrition before the intervention commenced.
“Of the 256 eligible participants for the Kunik 2008 study, 238 were randomised but only 181 attended their first session (24% attrition before the intervention commenced).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenAll three included studies recruited participants with both anxiety and depression, not just anxiety, and compared psychotherapy with co-intervention versus co-intervention alone.
“All three included studies recruited participants with both anxiety and depression, not just anxiety (which may confound the results) and compared psychotherapy with co-intervention versus co-intervention alone.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAnxiety can occur at any stage of COPD.
“Other studies suggest that anxiety can occur at any stage of COPD (Kim 2000;Heslop-Marshall 2014.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kim 2000 source
- cites Heslop-Marshall 2014
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe lifetime prevalence of GAD amongst people with COPD is estimated at between 10% and 15.8%.
“The lifetime prevalence of GAD in particular amongst people with COPD is estimated at between 10% and 15.8% (Brenes 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brenes 2003 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationRates of anxiety symptoms in people with COPD range from 13% to 51% and are higher than the rates in people with heart failure, cancer, and other medical conditions.
“Rates of anxiety symptoms in people with COPD range from 13% to 51% and are higher than the rates in people with heart failure, cancer, and other medical conditions (Brenes 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brenes 2003 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe prevalence of panic disorder in the COPD population is estimated to be ten times higher than the general population.
“The prevalence of panic disorder in the COPD population is estimated to be ten times higher than the general population (Smoller 1996;Smoler 1999).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Smoller 1996 source
- cites Smoler 1999
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOne model explains increased levels of anxiety and panic in people with COPD as catastrophic misinterpretations of ambiguous bodily sensations (such as shortness of breath, rapid heart rate) which increase arousal, creating a positive feedback loop that results in a panic attack.
“One model explains this relationship as catastrophic misinterpretations of ambiguous bodily sensations (such as shortness of breath, rapid heart rate) which increase arousal, creating a positive feedback loop that results in a panic attack (Clark 1986).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Clark 1986 source
May combine two claims.
PremisecitationCurrent evidence examining quality of life suggests a reduction in satisfaction above and beyond what should be expected by COPD disease severity or co-morbid medical illnesses, indicating that psychological status plays an intrinsic role in overall well-being.
“Current evidence examining quality of life suggests a reduction in satisfaction above and beyond what should be expected by COPD disease severity or co-morbid medical illnesses (Coventry 2007), indicating that psychological status plays an intrinsic role in overall well-being.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Coventry 2007 source
May combine two claims.
PremisecitationDyspnoea is an ambiguous sensation open to catastrophic interpretation, leading to increased levels of anxiety and panic in people with COPD.
“Dyspnoea (shortness of breath) can be an unpleasant and potentially frightening experience at any time, and, as the key symptom of an eventually fatal illness like COPD, it is an ambiguous sensation open to catastrophic interpretation, leading to increased levels of anxiety and panic in people with COPD (Livermore 2010b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Livermore 2010b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationA recent study found that people with COPD and anxiety felt isolated and would avoid social occasions and usual daily activities.
“A recent study examining the impact of anxiety on the lives of people with COPD found that they felt isolated and would avoid social occasions and usual daily activities (Willgoss 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Willgoss 2011
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationThe evidence for treatment of anxiety disorders in COPD is limited, and there are limited data to support the efficacy of medication-only treatments.
“The evidence for treatment of anxiety disorders in COPD is limited, and there are limited data to support the efficacy of medicationonly treatments (Borson 1998).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Borson 1998
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationAnxiety is common in COPD and is not correlated with COPD severity.
“Screening data from a large randomised controlled trial in the UK showed anxiety was common in COPD and was not correlated with COPD severity (Heslop-Marshall 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Heslop-Marshall 2014
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationAnxiety disorders in people with COPD increase disability and impair functional status, resulting in an overall reduction in their quality of life.
“Anxiety disorders in people with COPD have been shown to increase disability and impair functional status, resulting in an overall reduction in their quality of life (Beck 1988;Weaver 1997).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenTwo of three review authors retrieved and independently examined the full texts of studies identified as potentially relevant for final inclusion.
“Two of three review authors, as above, retrieved and independently examined the full texts of studies identified as potentially relevant for final inclusion.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataTwo independent review authors extracted data using a standardised and piloted data extraction form.
“Two independent review authors (a combination of ZU, KC and KHM) extracted the following data using a standardised and piloted data extraction form, for each included study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataTwo of three review authors independently assessed all citations generated from the search strategies to determine whether they satisfied the inclusion criteria.
“Two of three review authors (either KC, ZU or KHM) independently assessed all citations generated from the search strategies to determine whether they satisfied the Criteria for considering studies for this review, through screening of the title, abstract and descriptors.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationTwo review authors independently assessed the risk of bias for all included studies using the Cochrane tool for assessing risk of bias.
“Two review authors independently assessed the risk of bias for all the included studies using the Cochrane tool for assessing risk of bias, which is a domain-based evaluation (Higgins 2011a).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Higgins 2011a
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationown dataSome evidence of improvement in anxiety was observed favouring the psychological therapy arm, but substantial heterogeneity and low quality of evidence limit the reliability of these findings.
“Some evidence of improvement in anxiety was observed with a benefit in favour of the psychological therapy arm, however, the presence of substantial heterogeneity and low quality of the evidence limits the reliability of these findings.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningWe extracted data from cross-over studies for the first phase only (pre-cross-over), due to the potential for a significant carry-over effect for psychological therapies.
“We extracted data from cross-over studies for the first phase only (pre-cross-over), due to the potential for a significant carry-over effect for psychological therapies.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductcitationFor cluster-randomised studies, we performed analyses at the level of individuals, whilst accounting for the clustering in the data using a random-effects model for pooled meta-analysis.
“For cluster-randomised studies, we performed analyses at the level of individuals, whilst accounting for the clustering in the data using a random-effects model for pooled meta-analysis, as recommended in the Cochrane Handbook for Systematic Reviews of Interventions (chapter 16.3.3) (Higgins 2011b) (checked by a statistician (AE)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Higgins 2011b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Study design and conductown dataTwo included studies sufficiently reported allocation concealment, using an external statistician (Kunik 2008) and numbered identical containers (Hynninen 2010).
“Two studies sufficiently reported allocation concealment using an external statistician to provide treatment codes to the study coordinator once sufficient numbers of participants for two classes had been recruited (Kunik 2008) and by using numbered containers that were identical in appearance for the two groups (Hynninen 2010).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe de Godoy 2003 study did not report any details of allocation concealment.
“The de Godoy 2003 study did not report any details of allocation concealment.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataThe two remaining included studies reported randomisation as occurring but did not describe their methods in detail.
“The two remaining studies reported randomisation as occurring, however, they did not describe their methods in detail.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataSelective reporting was a low risk in two included studies due to available prespecified protocols, while de Godoy 2003 had unclear risk because no prespecified protocol could be reviewed.
“Selective reporting was a low risk in two studies due to the availability of prespecified published protocols, allowing adequate comparison of prespecified outcomes and those reported in the publications.We assessed the de Godoy 2003 study as having an unclear risk of bias due to the inability to review a prespecified protocol.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationFor studies that did not adjust for clustering, we replaced the actual sample size with the effective sample size (ESS), calculated using a rho = 0.02.
“For those studies that did not adjust for clustering, we replaced the actual sample size with the effective sample size (ESS), calculated using a rho = 0.02 (as per Campbell 2000).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Campbell 2000
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
InterpretationreasoningThe identification of six ongoing studies and one awaiting classification is reassuring, but there is a possibility of negative studies being missed before publication of protocols became mandatory.
“The identification of six ongoing studies and one awaiting classification is reassuring, however, there is the possibility of negative studies being missed before publication of protocols became mandatory.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataOutcome assessor blinding was unclear in two included studies and was assessed as low risk of bias in Kunik 2008.
“Outcome assessor blinding was unclear in two studies and assessed to be a low risk of bias in the Kunik 2008 study as authors reported that study personnel performing assessments were blinded to treatment condition.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenFor participants who dropped out after the second week or with unclear dropout time, we used the last observation carried forward (LOCF) as presented in the publications.
“For participants who dropped out a er the second week or with unclear dropout time, we used the last observation carried forward (LOCF) as presented in the publications, or had the data been missing we would have obtained raw data.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataTwo included studies did not blind participants or personnel to treatment allocation, while de Godoy 2003 reported that group 1 was blinded in relation to the activities of group 2 and vice versa.
“Two studies did not blind participants or personnel to the treatment allocation, whilst the third study (de Godoy 2003) reported that group 1 was blinded in relation to the activities of group 2 and vice versa.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationWe evaluated missing information regarding participants on an available case-analysis basis.
“We evaluated missing information regarding participants on an available case-analysis basis as described in chapter 16.2.2 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Higgins 2011b
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningFindings from this review should be interpreted with caution and the questions posed in this review remain unanswered.
“As such, findings from this review should be interpreted with caution and the questions posed in this review remain unanswered.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenWe performed a sensitivity analysis for studies which were at an unclear or high risk of bias for sequence generation and allocation concealment, and for studies involving participants who had significant co-morbidities.
“We assessed all the included studies for inclusion in the primary analyses, and performed a sensitivity analysis for studies which were at an unclear or high risk of bias for sequence generation and allocation concealment, and for studies involving participants who had significant co-morbidities, for example, dementia or severe heart failure.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningBecause only three studies were included, it is difficult to examine consistency effectively, and the quality of results was downgraded due to inconsistency.
“However, as we only included three studies, it is difficult effectively to examine consistency.As such, the quality of results was downgraded due to inconsistency.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenScreening of online clinical trial registries allows identification of studies regardless of a positive or negative effect, which may reduce the possibility of publication bias.
“Screening of online clinical trial registries allows identification of studies regardless of a positive or negative effect for the treatment, which may reduce the possibility of publication bias.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductreasoningAll three included studies had a low risk of bias for incomplete outcome data because they used intention-to-treat analyses.
“All three studies had a low risk of bias for incomplete outcome data as they used intention-to-treat analyses.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductreasoningWe pooled the extracted data in meta-analyses using the random-effects model to allow for expected heterogeneity.
“We pooled the extracted data in meta-analyses using the randomeffects model to allow for expected heterogeneity (due to expected differences in the interventions and populations).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMeta-analyses attempting to examine the impact of psychological interventions for anxiety in people with COPD have consistently identified a lack of methodologically rigorous evidence to support treatment efficacy, resulting in the inability to draw reliable conclusions.
“Meta-analyses attempting to examine the impact of psychological interventions for anxiety in people with COPD have consistently identified a lack of methodologically rigorous evidence to support treatment efficacy (Rose 2002;Mikkelsen 2004;Baraniak 2011), resulting in the inability to draw reliable conclusions.”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA 2014 overview examining the prevalence, impact and management of depression and anxiety in COPD found that the quality of evidence underpinning treatment varied considerably.
“A 2014 overview examining the prevalence, impact and management of depression and anxiety in COPD also found that the quality of evidence underpinning treatment varied considerably (Panagioti 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Panagioti 2014
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningAn additional limitation is that risk of bias categories were deemed unclear by review authors because individual study authors were not contacted for clarification or further information.
“An additional limitation relates to risk of bias categories deemed to be unclear by review authors, as we did not contact individual study authors for clarification or to obtain further information.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationIn Hynninen 2010, random sequence generation was at unclear risk of selection bias because randomisation was reported but methods were not described.
“Random sequence generation (selection bias) Unclear risk Randomisation reported however methods not described”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hynninen 2010 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationIn Hynninen 2010, allocation concealment was at low risk of selection bias because numbered containers identical in appearance were used.
“Allocation concealment (selection bias) Low risk Allocation concealment was implemented using numbered containers that were identical in appearance for the two groups”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hynninen 2010 source
May combine two claims.
Interpretationown dataSome evidence of improvement in anxiety was observed in the psychological therapy arm, but the low quality of evidence and substantial heterogeneity limit the ability to draw conclusions from these findings.
“Some evidence of improvement in anxiety was observed in the psychological therapy arm, however, the low quality of the evidence and presence of substantial heterogeneity limits our ability to draw any conclusions from these findings.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor Kunik 2008, allocation concealment was at low risk of selection bias.
“Allocation concealment (selection bias) Low risk The statistician provided randomisation numbers and treatment codes to the study co-ordinator when sufficient participants for two classes had completed the baseline assessment and consented to participate; the instructor assigned the treatment to the code initially by flipping a coin”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningFor Kunik 2008, selective reporting was at low risk of reporting bias.
“Selective reporting (reporting bias) Low risk Pre-specified protocol available and no selective reporting identified”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor de Godoy 2003, incomplete outcome data was at low risk of attrition bias.
“Incomplete outcome data (attrition bias) All outcomes Low risk Reasons for choosing not to participate prior to randomisation (n = 6 participants) and attrition post recruitment (n = 3 intervention participants) were reported for all participants”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSensitivity analyses were not conducted because the number of included studies in each meta-analysis was small.
“We did not conduct sensitivity analyses due to the small number of included studies reported within each meta-analysis.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor de Godoy 2003, blinding of outcome assessment was at unclear risk of detection bias.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk No mention of blinding for outcome assessors”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor de Godoy 2003, blinding of participants and personnel was at unclear risk of performance bias.
“Blinding of participants and personnel (performance bias) All outcomes Unclear risk Group 1 was blinded in relation to the activities of Group 2 and vice versa”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor Hynninen 2010, outcome measures were validated, with the exception of service use outcomes.
“Outcome measures validated?: yes, with the exception of service use outcomes”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor de Godoy 2003, selective reporting was at unclear risk of reporting bias.
“Selective reporting (reporting bias) Unclear risk Insuffient information due to lack of prespecified study protocol”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationIn Hynninen 2010, the target sample size from the power analysis (33 per arm) was not reached (25 in the intervention arm and 26 in the control arm).
“the target sample size identified as being necessary in the power analysis (33 in each arm) was not reached by the end of the study period (25 in the intervention arm and 26 in the control arm)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hynninen 2010 source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataFor Kunik 2008, the sample size calculation required 120 participants per group, but this number was not met.
“Also, the sample size calculation in the statistical analysis section stated that 120 participants per group would be required yet this n-value was not met”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor Kunik 2008, blinding of participants and personnel was at high risk of performance bias.
“Blinding of participants and personnel (performance bias) All outcomes High risk Participants and staff performing the intervention were not blinded to treatment allocation”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor de Godoy 2003, other bias was at low risk.
“Other bias Low risk No other biases identified”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor Kunik 2008, other bias was at low risk.
“Other bias Low risk No other biases identified”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataFor Hynninen 2010, missing data were addressed using intention-to-treat analysis, and missing data at one measurement point did not prevent including the individual in the analysis.
“Missing data addressed?: Yes, ITT analysis used and authors reported that missing data at one measurement point did not prevent including the individual in the analysis”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn Hynninen 2010, blinding of outcome assessment was at unclear risk of detection bias because there was no mention of blinding for outcome assessors.
“Blinding of outcome assessment (detection bias) All outcomes Unclear risk No mention of blinding for outcome assessors”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hynninen 2010 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor Kunik 2008, random sequence generation was at low risk of selection bias.
“Random sequence generation (selection bias) Low risk Randomisation list occurred via computer program (SAS) with blocks to provide appropriately equal numbers per class of COPD; instructor assigned treatment to the code initially by flip of coin”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataFor Kunik 2008, blinding of outcome assessment was at low risk of detection bias.
“Blinding of outcome assessment (detection bias) All outcomes Low risk Study personnel performing assessments were blinded to treatment condition”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn Hynninen 2010, there was low risk of other bias because no other biases were identified.
“Other bias Low risk No other biases identified”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hynninen 2010 source
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Subject headings and free-text words were identified for use from previous systematic reviews (Hooper 2018; Uphoff 2020; Usmani 2017), the Information Specialist, and the project team members.
“Subject headings and free-text words were identified for use from previous systematic reviews (Hooper 2018; Uphoff 2020; Usmani 2017), the Information Specialist, and the project team members.”
From Behavioural activation therapy for depression in adults with non-communicable diseases (2020) · cites this paper as Usmani 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Physical quality-of-life confidence interval changes sign
MajorThe results text gives an upper confidence limit of −0.08, which would exclude no effect. The analysis table instead gives +0.08, consistent with the reported P = 0.10.
“standardised mean difference (SMD) -0.40, 95% CI -0.88 to -0.08; participants = 289; studies = 2; I 2 = 61%; P = 0.10”
“Subtotal *** 143 146 100% -0.4[-0.88,0.08]Heterogeneity: Tau =0.08; Chi =2.56, df=1(P=0.11);I =60.97%Test for overall effect: Z=1.63(P=0.1)”
Walking-distance analysis uses a different model than stated
MinorThe methods say pooled meta-analyses used a random-effects model, but the main six-minute walking-distance analysis is labelled fixed-effect.
“We pooled the extracted data in meta-analyses using the randomeffects model to allow for expected heterogeneity”
“3 Six minute walking distance 2 268 Mean Difference (IV, Fixed, 95% CI) -2.78 [-58.49,52.94]”
Emotional quality-of-life subgroup estimates differ
MinorThe summary gives short- and long-term estimates of 0.05 and −0.09; the corresponding duration analysis gives −0.17 and −0.30.
“Sub-group analyses separating short-term (0 to 3 months; (SMD 0.05, 95% CI -0.18 to 0.28) and long-term follow-up (6 to 12 months; (SMD -0.09, 95% CI -0.32 to 0.14)”
“4.1 Short-term (0 to 3 months) 2 289 Std.Mean Difference (IV, Random, 95% CI) -0.17 [-0.93, 0.60] 4.2 Long-term (6 to 12 months) 2 289 Std.Mean Difference (IV, Random, 95% CI) -0.30 [-1.03, 0.44]”
Physical quality-of-life subgroup estimates differ
MinorThe summary reports short- and long-term estimates of −0.22 and −0.30, but the corresponding duration analysis reports −0.30 and −0.40.
“Sub-group analyses separating short-term (0 to 3 months; SMD -0.22, 95% CI -0.45 to 0.01; P = 0.06) and long-term follow-up (6 to 12 months; SMD -0.30, 95% CI -0.53 to -0.06; P = 0.01)”
“3.1 Short-term (0 to 3 months) 2 289 Std.Mean Difference (IV, Random, 95% CI) -0.30 [-0.73, 0.13] 3.2 Long-term (6 to 12 months) 2 289 Std.Mean Difference (IV, Random, 95% CI) -0.40 [-0.88, 0.08]”
Listed dropout reasons exceed the dropout count
MinorThe five stated reason counts total 109, whereas the passage says 69 participants dropped out.
Reported 69 · recomputed 109
“Withdrawals and exclusions: 69 participants dropped out following randomisation(because of the following reasons: medical 2, no time 6,transportation 6,no interest 49, no information 46).”
Ongoing and awaiting-study counts are reversed
MinorThe search results assign seven studies to awaiting classification and two to ongoing status. The dedicated sections give the opposite counts.
“Seven studies are awaiting classification and two were ongoing at the time of review completion”
“We identified seven studies as ongoing at the time of review completion.”
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139 · see citing works
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032 · see citing works
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works
(1970) · Cited by 24,983 · see citing works
Diagnostic and Statistical Manual of Mental Disorders
(2012) · Springer eBooks · doi:10.1007/springerreference_121117 · Cited by 20,769 · see citing works
Psychophysical bases of perceived exertion
BORG, G. A. V. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198205000-00012 · Cited by 16,580 · see citing works
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983 · see citing works
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152 · see citing works
Selective Cortical Undercutting As a Means of Modifying and Studying Frontal Lobe Function in Man
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,373 · see citing works
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925 · see citing works
(2008) · Cited by 3,790 · see citing works
Chapter 9: Analysing Data and Undertaking Meta-Analyses
Deeks, J. J., Higgins, J. P. T., & Altman, D. G. (2008) · Cited by 2,782 · see citing works
The St George's Respiratory Questionnaire
Jones, P., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,729 · see citing works
Rabe, K. F. (2007) · American Journal of Respiratory and Critical Care Medicine · Cited by 2,567 · see citing works
Clark, D. M. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90011-2 · Cited by 2,422 · see citing works
Two-, six-, and 12-minute walking tests in respiratory disease.
Butland, R. J., Pang, J., Gross, E. R., Woodcock, A. A., & Geddes, D. M. (1982) · BMJ · doi:10.1136/bmj.284.6329.1607 · Cited by 1,668 · see citing works
Kaplan & Sadock's Comprehensive Textbook of Psychiatry
Sadock, B. J., & Sadock, V. A. (2000) · Cited by 1,523 · see citing works
A new intellectual framework for psychiatry
Kandel, E. R. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.4.457 · Cited by 1,271 · see citing works
Kaplan and Sadock's Comprehensive Text Book of Psychiatry
Saldanha, D. (2005) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(05)80189-3 · Cited by 1,164 · see citing works
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111 · see citing works
Chapter 10: Addressing reporting biases
Egger, M., & Moher, D. (2011) · Cited by 977 · see citing works
Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (2013) · PsycTESTS Dataset · doi:10.1037/t03589-000 · Cited by 946 · see citing works
Ries, A. L., Kaplan, R. M., Limberg, T. M., & Prewitt, L. M. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-11-199506010-00003 · Cited by 903 · see citing works
Anxiety and Depression in COPD
Maurer, J., Rebbapragada, V., Borson, S., Goldstein, R., Kunik, M. E., Yohannes, A. M., & Hanania, N. A. (2008) · Chest · doi:10.1378/chest.08-0342 · Cited by 720 · see citing works
Chapter 16: Special Topics in Statistics
Higgins, J. P. T., Deeks, J. J., & Altman, D. (2008) · Cited by 702 · see citing works
Anxiety and depression in COPD patients: the roles of gender and disease severity
Di Marco, F., Verga, M., Reggente, M., Maria Casanova, F., Santus, P., Blasi, F., Allegra, L., & Centanni, S. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.01.026 · Cited by 474 · see citing works
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression
Gudmundsson, G., Gislason, T., Janson, C., Lindberg, E., Hallin, R., Ulrik, C. S., Brøndum, E., Nieminen, M. M., Aine, T., & Bakke, P. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00078504 · Cited by 366 · see citing works
Bidirectional Associations Between Clinically Relevant Depression or Anxiety and COPD
Atlantis, E., Fahey, P., Cochrane, B., & Smith, S. (2013) · Chest · doi:10.1378/chest.12-1911 · Cited by 354 · see citing works
Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review
Mikkelsen, R. L., Middelboe, T., Pisinger, C., & Stage, K. B. (2004) · Nordic Journal of Psychiatry · doi:10.1080/08039480310000824 · Cited by 345 · see citing works
Anxiety and chronic obstructive pulmonary disease: prevalence, impact and treatment
Brenes, G. A. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000097339.75789.81 · Cited by 339 · see citing works
Functional impairment in COPD patients: the impact of anxiety and depression
Kim, H. F. S., Kunik, M. E., Molinari, V. A., Hillman, S. L., Lalani, S., Orengo, C. A., Petersen, N. J., Nahas, Z., & Goodnight-White, S. (2000) · Psychosomatics · doi:10.1176/appi.psy.41.6.465 · Cited by 310 · see citing works
Sample Size Calculations for Cluster Randomised Trials
Campbell, M., Grimshaw, J., Steen, N., & Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action) (2000) · Journal of Health Services Research & Policy · doi:10.1177/135581960000500105 · Cited by 298 · see citing works
Influence of anxiety on health outcomes in COPD
Eisner, M. D., Blanc, P. D., Yelin, E. H., Katz, P. P., Sanchez, G., Iribarren, C., & Omachi, T. A. (2010) · Thorax · doi:10.1136/thx.2009.126201 · Cited by 284 · see citing works
Nutt, D. J. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220033004 · Cited by 272 · see citing works
Statistics Notes: Units of analysis
Altman, D. G., & Martin Bland, J. (1997) · BMJ · doi:10.1136/bmj.314.7098.1874 · Cited by 271 · see citing works
Panic Anxiety, Dyspnea, and Respiratory Disease. Theoretical and Clinical Considerations
Smoller, J. W., Pollack, M. H., Otto, M. W., Rosenbaum, J. F., & Kradin, R. L. (1996) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.154.1.8680700 · Cited by 270 · see citing works
Coventry, P., Panagioti, M., Scott, C., & Blakemore, A. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s72073 · Cited by 249 · see citing works
Gillis, M. M., Haaga, D. A. F., & Ford, G. T. (1995) · Psychological Assessment · doi:10.1037/1040-3590.7.4.450 · Cited by 236 · see citing works
Kunik, M. E., Veazey, C., Cully, J. A., Souchek, J., Graham, D. P., Hopko, D., Carter, R., Sharafkhaneh, A., Goepfert, E. J., Wray, N., et al. (2008) · Psychological Medicine · doi:10.1017/s0033291707001687 · Cited by 214 · see citing works
KUNIK, M. E., BRAUN, U., STANLEY, M. A., WRISTERS, K., MOLINARI, V., STOEBNER, D., & ORENGO, C. A. (2001) · Psychological Medicine · doi:10.1017/s0033291701003890 · Cited by 204 · see citing works
Coventry, P. A., & Hind, D. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.08.002 · Cited by 197 · see citing works
de Godoy, D. V., & de Godoy, R. F. (2003) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/s0003-9993(03)00239-9 · Cited by 171 · see citing works
Coventry, P. A., Bower, P., Keyworth, C., Kenning, C., Knopp, J., Garrett, C., Hind, D., Malpass, A., & Dickens, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060532 · Cited by 157 · see citing works
A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD
Hynninen, M. J., Bjerke, N., Pallesen, S., Bakke, P. S., & Nordhus, I. H. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.02.020 · Cited by 152 · see citing works
Agoraphobia, the panic attack and the hyperventilation syndrome
Ley, R. (1985) · Behaviour Research and Therapy · doi:10.1016/0005-7967(85)90145-7 · Cited by 150 · see citing works
Relaxation to Reduce Dyspnea and Anxiety in COPD Patients
Gift, A. G., MOORE, T., & Soeken, K. L. (1992) · Nursing Research · doi:10.1097/00006199-199207000-00011 · Cited by 148 · see citing works
Yohannes, A. M., Connolly, M. J., & Baldwin, R. C. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.461 · Cited by 124 · see citing works
Livermore, N., Sharpe, L., & McKenzie, D. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.04.011 · Cited by 99 · see citing works
Doyle, T. A., Palmer, S. M., Johnson, J. M., Babyak, M. A., Smith, P. J., Mabe, S., Welty‐Wolf, K. E., Martinu, T., & Blumenthal, J. A. (2013) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.45.2.g · Cited by 95 · see citing works
Lolak, S., Connors, G. L., Sheridan, M. J., & Wise, T. N. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000112889 · Cited by 94 · see citing works
Depression and anxiety in elderly patients with chronic obstructive pulmonary disease
Yohannes, A. M., Baldwin, R., & Connolly, M. J. (2006) · Age and Ageing · doi:10.1093/ageing/afl011 · Cited by 93 · see citing works
Baraniak, A., & Sheffield, D. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2010.04.010 · Cited by 90 · see citing works
Prevention of panic attacks and panic disorder in COPD
LIVERMORE, N., Sharpe, L., & McKenzie, D. (2009) · European Respiratory Journal · doi:10.1183/09031936.00060309 · Cited by 90 · see citing works
The Effectiveness of Different Combinations of Pulmonary Rehabilitation Program Components
Norweg, A. M., Whiteson, J., Malgady, R., Mola, A., & Rey, M. (2005) · Chest · doi:10.1378/chest.128.2.663 · Cited by 89 · see citing works
Effectiveness of acupressure in improving dyspnoea in chronic obstructive pulmonary disease
Wu, H., Wu, S., Lin, J., & Lin, L. (2004) · Journal of Advanced Nursing · doi:10.1046/j.1365-2648.2003.02886.x · Cited by 84 · see citing works
Rose, C., Wallace, L., Dickson, R., Ayres, J., Lehman, R., Searle, Y., & Sherwood Burge, P. (2002) · Patient Education and Counseling · doi:10.1016/s0738-3991(02)00004-6 · Cited by 82 · see citing works
Change in monoamine transporter density related to clinical recovery: a case control study
Viinamäki, H., Kuikka, J., Tiihonen, J., & Lehtonen, J. (1998) · Nordic Journal of Psychiatry · doi:10.1080/080394898422553 · Cited by 81 · see citing works
An explanatory model of functional status in chronic obstructive pulmonary disease
WEAVER, T. E., RICHMOND, T. S., & NARSAVAGE, G. L. (1997) · Nursing Research · doi:10.1097/00006199-199701000-00005 · Cited by 76 · see citing works
Lamers, F., Jonkers, C. C. M., Bosma, H., Chavannes, N. H., Knottnerus, J. A., & van Eijk, J. T. M. (2010) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2010.510156 · Cited by 74 · see citing works
Cully, J. A., Armento, M. E. A., Mott, J., Nadorff, M. R., Naik, A. D., Stanley, M. A., Sorocco, K. H., Kunik, M. E., Petersen, N. J., & Kauth, M. R. (2012) · Implementation Science · doi:10.1186/1748-5908-7-64 · Cited by 72 · see citing works
Depression and Chronic Obstructive Pulmonary Disease: Treatment Trials.
Borson, S., Claypoole, K. H., & McDonald, G. (1998) · PubMed · Cited by 70 · see citing works
Blumenthal, J. A., Emery, C. F., Smith, P. J., Keefe, F. J., Welty‐Wolf, K. E., Mabe, S., Martinu, T., Johnson, J. J., Babyak, M. A., O’Hayer, V. F., et al. (2014) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000101 · Cited by 62 · see citing works
Panic disorder: from respiration to the homeostatic brain
Perna, G., Caldirola, D., & Bellodi, L. (2004) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2004.0080.x · Cited by 61 · see citing works
Pollok, J., van Agteren, J. E., & Carson-Chahhoud, K. V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012346.pub2 · Cited by 59 · see citing works
Self-citationYohannes, A. M., Baldwin, R. C., & Connolly, M. J. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200012)15:12 · Cited by 58 · see citing works
The role of social support in anxiety for persons with COPD
DiNicola, G., Julian, L., Gregorich, S. E., Blanc, P. D., & Katz, P. P. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.09.022 · Cited by 58 · see citing works
Usmani, Z. A., Carson, K. V., Cheng, J. N., Esterman, A. J., & Smith, B. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008483.pub2 · Cited by 57 · see citing works
Self-citationThe impact of chronic obstructive pulmonary disease-related fears on disease-specific disability
Keil, D. C., Stenzel, N. M., Kühl, K., Vaske, I., Mewes, R., Rief, W., & Kenn, K. (2014) · Chronic Respiratory Disease · doi:10.1177/1479972313516881 · Cited by 54 · see citing works
Livermore, N., Dimitri, A., Sharpe, L., McKenzie, D. K., Gandevia, S. C., & Butler, J. E. (2015) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2015.05.013 · Cited by 51 · see citing works
Rl, B., Vandiver, T. A., Braun, S., Dd, B., & Straub, V. (1990) · PubMed · Cited by 38 · see citing works
Heslop, K., Newton, J. L., Baker, C., Burns, G., Carrick‐Sen, D., & Soyza, A. D. (2013) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-13-62 · Cited by 36 · see citing works
Self-citationCorrelates of daily impairment in COPD.
Beck, J. G., Scott, S. K., Teague, R. B., Perez, F. I., & al, E. (1988) · Rehabilitation Psychology · doi:10.1037//0090-5550.33.2.77 · Cited by 33 · see citing works
Pommer, A. M., Pouwer, F., Denollet, J., & Pop, V. J. M. (2012) · Trials · doi:10.1186/1745-6215-13-6 · Cited by 30 · see citing works
Anxiety in patients with pulmonary disease: comorbidity and treatment.
Smoller, J. W., SIMON, N. M., Mh, P., Kradin, R. L., & Stern, T. (1999) · PubMed · doi:10.1053/scnp00400084 · Cited by 29 · see citing works
Suh, S., Ellis, R. J., Sollers, J. J., Thayer, J. F., Yang, H.-C., & Emery, C. F. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.02.007 · Cited by 28 · see citing works
Correlates of daily impairment in COPD
Beck, J. G., Scott, S. K., Teague, R. B., Perez, F. I., & Brown, G. A. (1988) · Rehabilitation Psychology · doi:10.1037/h0091681 · Cited by 26 · see citing works
The impact of psychological distress on exacerbation rates in COPD
Laurin, C., Moullec, G., Bacon, S. L., & Lavoie, K. L. (2011) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810382818 · Cited by 25 · see citing works
Bové, D. G., Overgaard, D., Lomborg, K. E., Lindhardt, B. Ø., & Midtgaard, J. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008031 · Cited by 25 · see citing works
COPD and anxiety: its impact on patients' lives.
Willgoss, T. G., Yohannes, A. M., Goldbart, J., & Fatoye, F. (2011) · PubMed · Cited by 25 · see citing works
de Godoy, D. V., de Godoy, R. F., Júnior, B. B., Vaccari, P. F., Michelli, M., Teixeira, P. J. Z., & Palombini, B. C. (2005) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132005000600007 · Cited by 24 · see citing works
Breland, J. Y., Hundt, N. E., Fletcher, T. L., Mignogna, J., Petersen, N. J., Stanley, M. A., & Cully, J. A. (2015) · International Journal of Behavioral Medicine · doi:10.1007/s12529-014-9450-2 · Cited by 22 · see citing works
Elassal, G., Elsheikh, M., & Abu Zeid, A. G. (2014) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2014.02.013 · Cited by 14 · see citing works
Kerstjens, H. A. M., Groen, H. J., & van der Bij, W. (2001) · BMJ · doi:10.1136/bmj.323.7325.1349 · Cited by 14 · see citing works
Are We Missing Anxiety in People with Chronic Obstructive Pulmonary Disease (COPD)
Heslop-Marshall, K., Soyza, A. D., Consultant, N., & Physician, C. (2014) · Cited by 7 · see citing works
Self-citationUsmani, Z. A., Carson‐Chahhoud, K., Heslop, K., Esterman, A. J., Soyza, A. D., & Smith, B. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010673 · Cited by 4 · see citing works
Self-citationCognitive Behavioral Therapy for Anxiety and Depression
Hofmann, S. G., & Smits, J. A. J. (2017) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(17)30082-5 · Cited by 3 · see citing works
Tan, S. K., Benedicto, J., & Santiaguel, J. M. (2013) · European Respiratory Journal · Cited by 2 · see citing works
Phan, T., Carter, O. B. J., WATERER, G. W., et al. (2015) · Edith Cowan University Research Online (Edith Cowan University) · Cited by 1 · see citing works
Phan, T., Ziman, M. R., Strobel, N., et al. (2018) · Australasian Journal of Paramedicine · Cited by 1 · see citing works
Flagged first, then by citations
6 of the 97 references couldn’t be matched to a known paper.
Research works printed but not linked: 7
- Aubuchon, 1990, The effects of positive mental imagery on hope, coping, anxiety, dyspnea and pulmonary function in persons with chronic obstructive pulmonary disease: tests of a nursing intervention and a theoretical model [Dissertation]
- Shao, 2003, Effects of the behavioral intervention on the life quality of the patients with chronic obstructive pulmonary disease in remission period, Zhonghua Linchuang Kangfu Zazhi, 7, 4078
- Beck, 1993, Beck Anxiety Inventory: A Manual
- Davison, 2003, Abnormal Psychology
- Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
- Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
- Schünemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org
Cited by
Sorted by citations
Maddocks, M. M., Lovell, N., Booth, S., Man, W. D., & Higginson, I. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32127-x · Cited by 225 · see citing works
Fordham, B., Sugavanam, T., Edwards, K., Stallard, P., Howard, R., das Nair, R., Copsey, B., Lee, H., Howick, J., Hemming, K., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291720005292 · Cited by 179 · see citing works
“, 2008) included in a higher-quality review (Usmani et al., 2017).”
BackgroundThe Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease
Rahi, M. S., Thilagar, B., Balaji, S., Prabhakaran, S. Y., Mudgal, M., Rajoo, S., Yella, P. R., Satija, P., Zagorulko, A., & Gunasekaran, K. (2023) · Advances in respiratory medicine · doi:10.3390/arm91020011 · Cited by 137 · see citing works
“Even though the quality of evidence was low, there were improvements in anxiety scores over 3 to 12 months when combining psychological therapies with a co-intervention [70].”
BackgroundPatel, K. R., Lee, H. H., Rastogi, S., Vakharia, P. P., Hua, T., Chhiba, K. D., Singam, V., & Silverberg, J. I. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.11.068 · Cited by 105 · see citing works
Randomised controlled trial of cognitive behavioural therapy in COPD
Heslop-Marshall, K., Baker, C., Carrick-Sen, D., Newton, J., Echevarria, C., Stenton, C., Jambon, M., Gray, J., Pearce, K., Burns, G., et al. (2018) · ERJ Open Research · doi:10.1183/23120541.00094-2018 · Cited by 97 · see citing works
Effects of exercise on symptoms of anxiety in primary care patients: a randomized controlled trial
Henriksson, M., Wall, A., Nyberg, J., Adiels, M., Lundin, K., Bergh, Y., Eggertsen, R., Danielsson, L., Kuhn, H. G., Westerlund, M., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.10.006 · Cited by 91 · see citing works
Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management
Yohannes, A. M., Kaplan, A. G., & Hanania, N. A. (2018) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.85.s1.03 · Cited by 94 · see citing works
“83 In addition, it is important that caregivers are supported in the management of patients with COPD and comorbid anxiety and/or depression; areas in which caregivers can be assisted in their role may include disease education and counseling, where appropriate.”
BackgroundBekelman, D. B., Feser, W. J., Morgan, B. R., Welsh, C. H., Parsons, E. C., Paden, G., Barón, A. E., Hattler, B. G. J., McBryde, C. F., Cheng, A. M., et al. (2024) · JAMA · doi:10.1001/jama.2023.24035 · Cited by 102 · see citing works
Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease
Pollok, J., van Agteren, J. E., Esterman, A. J., & Carson‐Chahhoud, K. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012347.pub2 · Cited by 91 · see citing works
Self-citationPollok, J., van Agteren, J. E., & Carson-Chahhoud, K. V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012346.pub2 · Cited by 59 · see citing works
Self-citationSerotonergic antidepressant use and morbidity and mortality among older adults with COPD
Vozoris, N. T., Wang, X., Austin, P. C., Stephenson, A. L., O’Donnell, D. E., Gershon, A. S., Gill, S. S., & Rochon, P. A. (2018) · European Respiratory Journal · doi:10.1183/13993003.00475-2018 · Cited by 54 · see citing works
Fordham, B., Sugavanam, T., Edwards, K., Hemming, K., Howick, J., Copsey, B. J., Lee, H., Kaidesoja, M., Kirtley, S., Hopewell, S., et al. (2021) · Health Technology Assessment · doi:10.3310/hta25090 · Cited by 59 · see citing works
Nonpharmacological management of psychological distress in people with COPD
Volpato, E., Farver-Vestergaard, I., Brighton, L. J., Peters, J. B., Verkleij, M., Hutchinson, A., Heijmans, M., & von Leupoldt, A. (2023) · European Respiratory Review · doi:10.1183/16000617.0170-2022 · Cited by 53 · see citing works
Zhang, X., Yin, C., Tian, W., Dong-bing, L., & Yang, X. (2020) · The Clinical Respiratory Journal · doi:10.1111/crj.13226 · Cited by 36 · see citing works
“(1) Population: patients with COPD, all patients were treated with standard COPD medications, including bronchodilators, and oral corticosteroids and/or oxygenation when appropriate; (2) Intervention: CBT; (3) Comparison: usual care or health education intervention or blank control; (4) Study design: RCT, Language lim…”
BackgroundMethodAnxiety Disorders in Patients With Somatic Diseases
Henning, M., Subič-Wrana, C., Wiltink, J., & Beutel, M. E. (2020) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000779 · Cited by 34 · see citing works
“of the studies, the authors considered the findings only as lowquality evidence for the efficacy of psychological treatments (65).”
BackgroundTaylor, S. J., Sohanpal, R., Steed, L., Heslop-Marshall, K., Chan, C. L., Yaziji, N., Barradell, A. C., Font-Gilabert, P., Healey, A., Hooper, R., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.00432-2023 · Cited by 37 · see citing works
“A Cochrane review of psychological therapies for the treatment of anxiety in COPD identified only three studies, all of which included patients with anxiety and depression [36].”
BackgroundBehavioural activation therapy for depression in adults with non-communicable diseases
Uphoff, E., Pires, M., Barbui, C., Barua, D., Churchill, R., Cristofalo, D., Ekers, D., Fottrell, E., Mazumdar, P., Purgato, M., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013461.pub2 · Cited by 33 · see citing works
“Subject headings and free-text words were identified for use from previous systematic reviews (Hooper 2018; Upho 2020; Usmani 2017), the Information Specialist, and the project team members.”
BackgroundMethodInfluentialDennett, E. J., Janjua, S., Stovold, E. M., Harrison, S. L., McDonnell, M. J., & Holland, A. E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013384.pub2 · Cited by 27 · see citing works
Psychosocial Interventions for Patients with Severe COPD—An Up-to-Date Literature Review
Rzadkiewicz, M., & Nasiłowski, J. (2019) · Medicina · doi:10.3390/medicina55090597 · Cited by 28 · see citing works
“Thus, it is difficult to understand the methodological approach in some studies where, despite a small sample size, the patients’ treatments, or even COPD stages, are neither provided nor included in analyses [57,62].”
BackgroundCognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review
Williams, M., Johnston, K., & Paquet, C. (2020) · International Journal of COPD · doi:10.2147/copd.s178049 · Cited by 55 · see citing works
Zarghami, M., Taghizadeh, F., Sharifpour, A., & Alipour, A. (2018) · PubMed Central · doi:10.22122/ahj.v10i3.600 · Cited by 22 · see citing works
Kubincová, A., Takáč, P., Kendrová, L. D., Joppa, P., & Mikuľákova, W. (2018) · Medical Science Monitor · doi:10.12659/msm.909777 · Cited by 22 · see citing works
Farver-Vestergaard, I., Danielsen, J. T., Løkke, A., & Zachariae, R. H. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001043 · Cited by 21 · see citing works
“The small magnitude of the ESs found in the present study is generally comparable to ESs of psychosocial intervention on psychological outcomes found in other recent meta-analyses of subsamples of the available studies (7,8).”
BackgroundResultComorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis
Millan‐Billi, P., Serra, C., Leon, A. A., & Castillo, D. (2018) · Medical Sciences · doi:10.3390/medsci6030059 · Cited by 19 · see citing works
“In the same line, a recent Cochrane review [47] highlighted the need for additional study of pharmacologic treatment of anxiety in chronic obstructive pulmonary disease (COPD), which could also be applied to the population with IPF.”
BackgroundEffects of a Digital Self-care Intervention in Adults with COPD: A Pilot Study
Bugajski, A., Frazier, S. K., Cousin, L., Rechenberg, K., Brown, J. D., Lengerich, A. J., Moser, D. K., & Lennie, T. A. (2019) · Western Journal of Nursing Research · doi:10.1177/0193945919892282 · Cited by 17 · see citing works
COPD and Comorbid Mental Health: Addressing Anxiety, and Depression, and Their Clinical Management
Siraj, R. A. (2025) · Medicina · doi:10.3390/medicina61081426 · Cited by 24 · see citing works
“…reuptake inhibitors (SSRIs)/serotonin–norepinephrine reuptake inhibitors (SNRIs)) Non-pharmacological interventions are strongly recommended as a first-line treatment for anxiety and depression in COPD; the evidence for their efficacy can be comparable with that of pharmacological therapies [66].”
Chen, X., Guo, Y., Zhang, T.-X., Lin, J.-M., & Ding, X. (2024) · Worldviews on Evidence-Based Nursing · doi:10.1111/wvn.12705 · Cited by 14 · see citing works
Williams, M., Lewthwaite, H., Paquet, C., Cafarella, P., & Frith, P. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237286 · Cited by 16 · see citing works
Clinical management of COVID-19
World Health Organization (2025) · World Health Organization eBooks · doi:10.2471/b09467 · Cited by 17 · see citing works
The role of cognitive behavioural therapy in living well with COPD
Heslop-Marshall, K., & Burns, G. (2019) · Breathe · doi:10.1183/20734735.0119-2019 · Cited by 14 · see citing works
“Recent studies have demonstrated the value of psychological therapy, with promising results for cognitive behavioural therapy (CBT) in the treatment of anxiety and depression in COPD [10, 15, 16].”
BackgroundPsychosocial Support in Pulmonary Rehabilitation
Yohannes, A. M. (2024) · Respiratory Care · doi:10.4187/respcare.11850 · Cited by 12 · see citing works
“41,42 Usmani and colleagues 42 systematically reviewed the effectiveness of CBT in subjects with COPD and comorbid anxiety symptoms.”
Accuracy of Expected Symptoms and Subsequent Quality of Life Measures Among Adults With COPD
Hart, J. L., Summer, A., Ogunduyile, L., Lapite, F. C., Hong, D., Whitman, C., Blette, B. S., Harhay, M. O., & Halpern, S. D. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.44030 · Cited by 15 · see citing works
Anxiety and Depression Among US Nursing Home Residents with Chronic Obstructive Pulmonary Disease
Osundolire, S., Goldberg, R. J., & Lapane, K. L. (2023) · International Journal of COPD · doi:10.2147/copd.s417449 · Cited by 11 · see citing works
“52–55 The extent to which these strategies would be effective in nursing home residents with COPD warrants further study.”
Stakeholders’ Views on Reducing Psychological Distress in Chronic Obstructive Pulmonary Disease
Hart, J. L., Hong, D., Summer, A., & Schnoll, R. A. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2021.06.021 · Cited by 12 · see citing works
Barrueco-Otero, E., HERNÁNDEZ-MEZQUITA, M. Á., Hidalgo-Sierra, V., Cordovilla, R., Pueyo, J. O., & Galán, J. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070713 · Cited by 7 · see citing works
“…prevalence in patients with COPD is highly variable, ranging from 6% to 70%, depending on the type of population [5], the severity of the disease [6], and the instruments used for diagnosis, but it is higher in COPD patients than in the healthy population; various authors have also reported an…”
BackgroundZampogna, E., Ferriero, G., Visca, D., et al. (2022) · Panminerva Medica · doi:10.23736/s0031-0808.22.04757-7 · Cited by 8 · see citing works
Nyberg, J., Henriksson, M., Åberg, N. D., Wall, A., Eggertsen, R., Westerlund, M., Danielsson, L., Kuhn, H. G., Wærn, M., & Åberg, M. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2169-5 · Cited by 8 · see citing works
“We have calculated, based on other studies [41, 42], that an effect size of 0.”
MethodA deep learning method for contactless emotion recognition from ballistocardiogram
Yu, X., Zou, Y., Mou, X., Li, S., Bai, Z., Du, L., Li, Z., Wang, P., Chen, X., Li, X., et al. (2024) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2024.106891 · Cited by 7 · see citing works
Abudiab, S., & Fuller‐Thomson, E. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192316337 · Cited by 7 · see citing works
Nurse-led cognitive behavioural therapy for treatment of anxiety in COPD
Yohannes, A. M. (2018) · ERJ Open Research · doi:10.1183/23120541.00221-2018 · Cited by 7 · see citing works
Sohanpal, R., Mammoliti, K., Barradell, A. C., Kelly, M. J., Newton, S., Steed, L., Wileman, V., Rowland, V., Dibao-Dina, C., Moore, A., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-11370-9 · Cited by 5 · see citing works
“Psychological treatment using cognitive-behavioural therapy (CBT) is an effective treatment for anxiety and depression but there is less evidence of benefit in COPD-related depression [24, 25] and anxiety [25, 26].”
BackgroundMethodAnxiety and post-traumatic stress disorders in patients with chronic respiratory diseases
Yohannes, A. M. (2023) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000670 · Cited by 5 · see citing works
“The systematic review highlighted the low-quality evidence for the ef fi cacy of psychological therapies among people with COPD with anxiety [39].”
Backgroundvon Leupoldt, A., Brighton, L. J., Peters, J. B., Volpato, E., Verkleij, M., Hutchinson, A., Heijmans, M., Farver-Vestergaard, I., Langer, D., & Spruit, M. A. (2020) · European Respiratory Journal · doi:10.1183/13993003.01881-2020 · Cited by 5 · see citing works
Chen, K., Zhao, K., Wang, W., et al. (2020) · Medicine · doi:10.1097/md.0000000000023220 · Cited by 4 · see citing works
“[4] Depression is an important complication of COPD, with a prevalence of up to 80% in the severe phase of COPD,[5] and its severity is closely related to the severity and acute exacerbation of COPD,[6,7] greatly associated with increased risk of mortality related COPD.”
BackgroundInfluentialOliveira, A., Rutter, M., Quijano-Campos, J. C., Herrero‐Cortina, B., Clari, M., O'Rourke, A., McGowan, A., Burtin, C., Šajnić, A., & Brandt, J. D. (2020) · ERJ Open Research · doi:10.1183/23120541.00034-2020 · Cited by 4 · see citing works
Effect of physical therapy for chronic obstructive pulmonary disease
Gao, H., Gao, Y., Sun, P., et al. (2019) · Medicine · doi:10.1097/md.0000000000017241 · Cited by 4 · see citing works
“Despite its high incidence, the managements of COPD still suffered from limited efficacy in many patients.([4,13,14]) Physical therapy (PT) has reported to benefits patients with COPD for reducing dyspnea, and improving respiratory muscle strength, lung function, and quality of life.”
BackgroundUsmani, Z. A., Carson‐Chahhoud, K., Esterman, A., & Smith, B. J. (2018) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s166022 · Cited by 4 · see citing works
“However, there is limited evidence to support this practice within the COPD population.(19,20) There is currently a lack of randomized controlled trials to assess the effects of pharmacological interventions in people with COPD.”
BackgroundSelf-citationJacob, A., Garg, K., Dutta, K., Saini, V., Aggarwal, D., & Sidana, A. K. (2024) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2024.2849 · Cited by 4 · see citing works
McDonnell, A. S., Manning, J. C., Gardner, J., et al. (2023) · Nursing Children and Young People · doi:10.7748/ncyp.2023.e1453 · Cited by 3 · see citing works
Papp, M. E., Nygren‐Bonnier, M., Gillerius, J., Wändell, P. E., & Lindfors, P. (2019) · Nordic Psychology · doi:10.1080/19012276.2019.1653220 · Cited by 3 · see citing works
“…means that randomized controlled trials (RCTs) including alternative interventions, such as breathing control, pulmonary rehabilitation exercises, and YE, while also evaluating the immediate and long-term effects (Usmani et al., 2017), are needed for patients with obstructive pulmonary disorders.”
BackgroundJanjua, S., McDonnell, M. J., Harrison, S. L., Dennett, E. J., Stovold, E. M., & Holland, A. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013384 · Cited by 3 · see citing works
“Pharmacological and psychological interventions aimed at treating the anxiety and depression are explored in a suite of Cochrane Reviews (Pollok 2018; Pollok 2019; Usmani 2011; Usmani 2017).”
BackgroundInfluentialMcMurray, M., Sisson, M. L., & Schiavon, S. P. (2020) · Respiratory medicine · doi:10.1007/978-3-030-44889-9_7 · Cited by 3 · see citing works
Chronic Obstructive Pulmonary Disease
Poehacker, S., Garg, M., & Drossel, C. (2018) · Springer eBooks · doi:10.1007/978-3-319-70539-2_11 · Cited by 2 · see citing works
Hart, J. L., Carter, D., Hinton, C., et al. (2026) · Trials · doi:10.1186/s13063-025-09210-0 · Cited by 1 · see citing works
“Clinicians often fail to recognize patients’ needs, lack sufficient resources to respond to needs when identified, and lack self-efficacy to explore and manage patients’ psychological distress [1, 11, 37, 40].”
Xin, Y., He, R., Ren, X., Yang, T., Wang, Y., & Su, X. (2025) · International Journal of COPD · doi:10.2147/copd.s566403 · Cited by 1 · see citing works
“42 Additionally, patients with a history of pulmonary infections may exhibit vaccine hesitancy, likely due to concerns about vaccine safety and effectiveness, particularly if they fear the vaccine might worsen their pulmonary condition 43.”
Ramos, S., Gomes, A. J. F., Rosinhas, A., da Silva, R. C. G., Goes, M., & Sampaio, F. (2025) · JBI Evidence Synthesis · doi:10.11124/jbies-24-00335 · Cited by 2 · see citing works
Barrueco, E., HERNÁNDEZ-MEZQUITA, M. Á., Hidalgo-Sierra, V., et al. (2024) · Preprints.org · doi:10.20944/preprints202406.0732.v2 · Cited by 1 · see citing works
Barrueco, E., HERNÁNDEZ-MEZQUITA, M. Á., Hidalgo-Sierra, V., et al. (2024) · Preprints.org · doi:10.20944/preprints202406.0732.v1 · Cited by 1 · see citing works
Factores psicológicos asociados a la enfermedad pulmonar obstructiva crónica: una revisión narrativa
Hernández‐Pérez, A., Vargas-Núñez, I., Pérez‐Padilla, R., & Ramírez‐Venegas, A. (2022) · NCT Neumología y Cirugía de Tórax · doi:10.35366/105530 · Cited by 1 · see citing works
Die palliative Versorgung von COPD-Patienten
Kahnert, K., Götschke, J., Bausewein, C., et al. (2020) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-020-0016-8 · Cited by 1 · see citing works
“Medikamentöse erapie Der Einsatz der antidepressiven erapie bei Patienten mit COPD und anderen Lungenerkrankungen ist leider immer noch unzureichend untersucht [16, 17, 18].”
BackgroundChronic Respiratory Abnormalities in the Multi-Morbid Frail Elderly
Beghé, B., Clini, E. M., & Fabbri, L. M. (2017) · Barcelona Respiratory Network · doi:10.23866/brnrev:2017-0056 · Cited by 7 · see citing works
Zhang, T., Wu, H., Bai, H., Zhou, Y., Zhu, Y., Li, W., Wang, S., In, J., Wubulikasimu, N., Xu, X., et al. (2026) · BMC Pulmonary Medicine · doi:10.1186/s12890-026-04331-x
“In recent years, cognitive behavioral therapy has been found to improve symptoms in patients with chronic airway diseases, such as chronic obstructive pulmonary disease and asthma [53, 54].”
Yu, J., Fu, J. H., Zhao, S., Zhang, S., Huang, R., Li, T., & Li, Y. (2026) · International Journal of COPD · doi:10.2147/copd.s574777
Grundlagen und Besonderheiten psychopneumologischer Interventionen
Köbler, P., Tempel, M., & Sütfels, G. (2026) · Springer eBooks · doi:10.1007/978-3-662-71757-8_7
Liang, L., Huang, Z., Zeng, Y., & Zhu, Z. (2025) · Psycho-Oncologie · doi:10.18282/po3600
Wang, L., Miao, D., Wang, M., He, G., Li, Z., Hou, Y., & Zhang, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-96007-5
Martyn, K., Anand, A., & Stanbrook, M. B. (2024) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2024.2359994
Grundlagen der Diagnostik und Therapie
(2024) · Elsevier eBooks · doi:10.1016/b978-3-437-22487-4.16001-0
Kapfhammer, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-65873-4_5
Medical Illness in Psychiatric Disease
Stiebel, V. G., & Nightingale, B. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-52520-0_17
Prevalencia de ansiedad y depresión en pacientes EPOC
Otero, E. B. (2021) · doi:10.14201/gredos.148549
Konsiliar- und Liaisondienste für psychische Störungen
Diefenbacher, A., Burian, R., & Härter, M. C. (2019) · Elsevier eBooks · doi:10.1016/b978-3-437-22485-0.00029-4
- Authors
- Usmani, Z. A., Carson, K. V., Heslop, K., Esterman, A. J., De Soyza, A., & Smith, B. J.
- Affiliations
- Queen Elizabeth Hospital (AU)
- The University of Adelaide; School of Medicine; Adelaide Australia
- Royal Victoria Infirmary (GB)
- University of South Australia (AU)
- Newcastle University; Institute of Cellular Medicine; Newcastle UK
- The University of Adelaide (AU)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-03-21
- Volume
- 2017
- Issue
- 3
- Pages
- CD010673-CD010673
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC6464539
- OpenAlex
- W2140629271
- Cited by
- 72
- References
- 97
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 8 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 10 · 2018: 10 · 2017: 3
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health and Care Research (CAT CDRF 10-023)
- University of Aberdeen
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- chronic obstructive pulmonary disease, anxiety disorders, psychotherapy, cognitive behavioral therapy, relaxation training, breathing exercises, COPD exacerbations, quality of life, dyspnea, exercise tolerance, treatment efficacy, adverse events, cost-effectiveness, cost-benefit analysis, cost-effectiveness ratio, benefit-cost ratio
- MeSH terms
- Anxiety Disorders, Emphysema, Female, Humans, Male, Psychotherapy, Quality of Life, Randomized Controlled Trials as Topic, Exercise Tolerance, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review